Biggest News Aggregation in the World
📰 Gpp Flares News

Gpp Flares News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Gpp Flares. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares

EFFISAYIL™ 2 met its primary and key secondary endpoint, demonstrating that spesolimab, an anti-interleukin-36 receptor antibody, can prevent flares in adolescents and adults with generalized pustular psoriasis (GPP) up to 48 weeks.1,2
Rheinland Pfalz Laura Lessenich Carinne Brouillon European Union Corporate Communications Boehringer Ingelheim

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science